Arama Sonuçları Guidelines - Daraltılmış: Drug development.SirsiDynix Enterprisehttps://katalog.hacettepe.edu.tr/client/tr_TR/default_tr/default_tr/qu$003dGuidelines$0026qf$003dSUBJECT$002509Konu$002509Drug$002bdevelopment.$002509Drug$002bdevelopment.$0026ic$003dtrue$0026ps$003d300?2026-01-21T22:35:19ZICH quality guidelines : an implementation guideent://SD_ILS/0/SD_ILS:5935762026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Teasdale, Andrew, editor. Elder, David (David P.), editor. Nims, Raymond W.<br/>Yer Numarası RM301.25<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781118971147">https://onlinelibrary.wiley.com/doi/book/10.1002/9781118971147</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Polypharmacology : strategies for multi-target drug discoveryent://SD_ILS/0/SD_ILS:5996222026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Peters, Jens-Uwe, editor.<br/>Yer Numarası RM301.25 .P65 2025<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781394182862">https://onlinelibrary.wiley.com/doi/book/10.1002/9781394182862</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>Analytical scientists in pharmaceutical product development : task management and practical knowledgeent://SD_ILS/0/SD_ILS:5960472026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Xiao, Kangping, author.<br/>Yer Numarası RM301.25 .X53 2021<br/>Elektronik Erişim <a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119547785</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>PAT applied in biopharmaceutical process development and manufacturing : an enabling tool for quality-by-designent://SD_ILS/0/SD_ILS:5390922026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Undey, Cenk.<br/>Yer Numarası RS380 .P37 2012<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439829462">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Active pharmaceutical ingredients : development, manufacturing, and regulationent://SD_ILS/0/SD_ILS:5401132026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Nusim, Stanley.<br/>Yer Numarası RM301.25 .A28 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781439803394">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical drug developmentent://SD_ILS/0/SD_ILS:5430282026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Rogge, Mark C. Taft, David R.<br/>Yer Numarası RM301.25 .P745 2010<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9781420084733">Click here to view.</a><br/>Format: Kitap<br/>Durum Çevrimiçi Kütüphane~1<br/>Preclinical Drug Developmentent://SD_ILS/0/SD_ILS:5401032026-01-21T22:35:19Z2026-01-21T22:35:19ZYazar Rogge, Mark C., editor. Taft, David R., editor. Taylor and Francis.<br/>Yer Numarası RM301.25 .P745 2005<br/>Elektronik Erişim <a href="https://www.taylorfrancis.com/books/9780429163210">Click here to view.</a><br/>Format: Elektrnik Kaynak<br/>Durum Çevrimiçi Kütüphane~1<br/>